Global diabetes prevalence is projected to rise sharply in the coming decades, with estimates indicating that as many as 900 million people worldwide could be living with the condition by 2050 if current trends continue. The findings come from the IDF Diabetes Atlas, a comprehensive global
Global pharmaceutical major Novo Nordisk has launched its blockbuster diabetes drug Ozempic in India, expanding access to one of the world’s most widely prescribed treatments for type 2 diabetes. The once-weekly injectable medication is now available across the country following regulatory approvals. Dosage and Pricing Details Ozempic will be sold in a pre-filled injection















